* RHENOVIA PHARMA *
2007 - Alsace
Mulhouse
www.rhenovia.com Contract, Research
Key words: Alzheimer, Biosimulation, Computational neuroscience, Memory
Mission: to contribute to discover new medicines against Alzheimer's and other central nervous system (CNS) diseases, by developing breakthrough biosimulation platforms for memory and other CNS functions
Clients: Pharmaceutical industry, Biotechs
info@rhenovia.com
Age: 5 year(s)
Identity| TYPE/MANAGEMENT/INVESTORS | FINANCES/STATUS |
|---|
| Personal venture |
Managing Dir.-CEO: Bischoff (Serge) [co-founder, born 1948, Ph.D. neuropharmacology, ex-Novartis]
Sc.Dir.-CSO: Baudry (Michel) [co-founder, born 1948, Eng. Ecole Polytechnique, Prof. engineering (Los Angeles), Ph.D.]
Oper.Dir.-COO: Faupel (Michel) [co-founder, ex-Novartis]
Fin.Dir.-CFO:
BusDev: George (Florian) [Ph.D. chemistry]
Financers (Hist.): privately owned, no outisde investors (registered capital 2007 = 0.126 M€) | Turnover (M€) : 0.092 (2009)
Total funding (M€) : 1.0
Last funding (M€) : 1.0
Focus : CNS
Position : Proof-of-Concept
Company confirm : none |
History | DATE | MILESTONE | TYPE | TIME |
|---|
| 2011 .05 | Partnering marketing agreement with Portmann Instruments for Rhenovia's biosimulation services in Switzerland | LICOUT | [4 years] |
| 2011 .04 | Partnering R&D agreement with Sodiaal-Candia for studying the nutritional and therapeutic value of milk and its derivatives | R&D | [3 years] |
| 2010 .12 | Partnering research collaborative project with AFM (Association Française des Myopathies) for 0.5 M€ over 2 years to support their simulation technology for diseases of the nervous system | R&D | [3 years] |
| 2010 .07 | Company headquarters move in new buildings, still in Mulhouse | ORGL | [3 years] |
| 2010 .04 | Partnering research collaborative project RHENEPI lead for 2.5 M€ over 3 years in order to develop a platform biosimulation of seizures (other partner Synapcell as CRO) | R&D | [2 years] |
| 2009 .04 | Financing (grant) : 1.6 M€ (2.3 MUS$), by state R&D institution NIH (USA) shared by Biomedical Engineering, LAS and Rhenovia, over 4 years | RFIN | [1 year] |
| 2007 .05 | Company founded by Serge Bischoff, Pr. Michel Baudry, Jan Kremers, and Michel Faupel | ORGF | [0 year] | Actualisation / Updating: 23-Sep-2011 |
|
